Mr Edmison reported receiving grants from the NIH during the conduct of the study. Mr Stevens-Ayers reported receiving grants from the NIH during the conduct of the study.
Ms Wagener reported receiving grants from the NIH during the conduct of the study. Dr Silveira reported receiving grants from the NIH during the conduct of the study and grants from Shire and Qiagen outside the submitted work. Dr Lyon reported receiving grants from Takeda Pharmaceutical Company outside the submitted work. Dr Razonable reported receiving grants from Roche and personal fees from Novartis and Merck outside the submitted work. Dr Winston reported receiving grants from Merk, Chimerix, Shire, Gilead, and Oxford Immunotech during the conduct of the study. Supervision: Singh, Razonable, Silveira, Stevens-Ayers, Edmison, Boeckh, Limaye.Ĭonflict of Interest Disclosures: Dr Singh reported receiving funding from the National Institutes of Health (NIH).
#Cid episode 1313 full
Corresponding Author: Nina Singh, MD, Division of Infectious Diseases, University of Pittsburgh, 3601 Fifth Ave, Falk Medical Bldg, Ste 5B, Pittsburgh, PA 15213 ( for Publication: February 26, 2020.Īuthor Contributions: Dr Singh and Ms Wagener had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.Ĭoncept and design: Singh, Winston, Lyon, Edmison, Boeckh, Limaye.Īcquisition, analysis, or interpretation of data: All authors.ĭrafting of the manuscript: Singh, Winston, Wagener, Limaye.Ĭritical revision of the manuscript for important intellectual content: All authors.Īdministrative, technical, or material support: Singh, Winston, Lyon, Silveira, Stevens-Ayers, Edmison, Boeckh, Limaye.
0 kommentar(er)
